ArticleJAMA ophthalmology2020

Safety and Vision Outcomes of Subretinal Gene Therapy Targeting Cone Photoreceptors in Achromatopsia: A Nonrandomized Controlled Trial.

M Dominik Fischer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.